loading
Ideaya Biosciences Inc stock is traded at $22.02, with a volume of 1.10M. It is up +0.96% in the last 24 hours and up +1.62% over the past month. IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
See More
Previous Close:
$21.81
Open:
$22.15
24h Volume:
1.10M
Relative Volume:
0.93
Market Cap:
$1.93B
Revenue:
$23.38M
Net Income/Loss:
$-155.22M
P/E Ratio:
-10.05
EPS:
-2.19
Net Cash Flow:
$-134.36M
1W Performance:
+2.75%
1M Performance:
+1.62%
6M Performance:
-4.84%
1Y Performance:
-48.48%
1-Day Range:
Value
$21.50
$22.38
1-Week Range:
Value
$21.33
$22.81
52-Week Range:
Value
$13.45
$44.42

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name
Name
Ideaya Biosciences Inc
Name
Phone
650-443-6209
Name
Address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA
Name
Employee
131
Name
Twitter
Name
Next Earnings Date
2024-11-05
Name
Latest SEC Filings
Name
IDYA's Discussions on Twitter

Compare IDYA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
IDYA
Ideaya Biosciences Inc
22.02 1.88B 23.38M -155.22M -134.36M -2.19
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-22-25 Initiated TD Cowen Buy
Jul-10-25 Resumed Goldman Neutral
Jun-26-25 Initiated Wells Fargo Overweight
Nov-18-24 Initiated Stephens Overweight
Nov-05-24 Downgrade Leerink Partners Outperform → Market Perform
Oct-24-24 Initiated UBS Buy
Oct-15-24 Initiated Cantor Fitzgerald Overweight
Jul-08-24 Initiated Mizuho Outperform
Mar-08-24 Initiated BTIG Research Buy
Aug-08-23 Initiated SVB Securities Outperform
May-24-23 Initiated Goldman Buy
Apr-24-23 Upgrade Stifel Hold → Buy
Mar-23-23 Initiated Berenberg Buy
Feb-28-23 Initiated RBC Capital Mkts Outperform
Dec-28-22 Initiated CapitalOne Overweight
Oct-27-22 Initiated Citigroup Buy
Aug-15-22 Downgrade Stifel Buy → Hold
Jul-18-22 Resumed Oppenheimer Outperform
Mar-10-22 Upgrade Stifel Hold → Buy
Sep-23-21 Initiated Stifel Hold
Jun-04-21 Resumed Robert W. Baird Outperform
Mar-11-21 Initiated Guggenheim Buy
Oct-07-20 Initiated Wedbush Outperform
Sep-01-20 Initiated Northland Capital Outperform
Jul-13-20 Upgrade JP Morgan Neutral → Overweight
Jun-17-20 Reiterated H.C. Wainwright Buy
Apr-06-20 Initiated H.C. Wainwright Buy
Mar-13-20 Initiated ROTH Capital Buy
Oct-17-19 Initiated Oppenheimer Outperform
Sep-10-19 Initiated Robert W. Baird Outperform
Jun-17-19 Initiated Citigroup Buy
Jun-17-19 Initiated JP Morgan Neutral
Jun-17-19 Initiated Jefferies Buy
View All

Ideaya Biosciences Inc Stock (IDYA) Latest News

pulisher
01:17 AM

IDEAYA Biosciences Inc. Stock Analysis and ForecastHigh-margin investment plays - jammulinksnews.com

01:17 AM
pulisher
Jul 22, 2025

Is IDEAYA Biosciences Inc. a good long term investmentRobust financial gains - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives IDEAYA Biosciences Inc. stock priceOver 200% growth - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Breakthrough Lung Cancer Drug IDE849 Shows First Human Results: 70+ Patient Data Coming at WCLC 2025 - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

Melanoma Market Anticipates a Dynamic Shift During the Forecast Period (2025–2034) Owing to the Strong Pipeline Activity | DelveInsight - GlobeNewswire Inc.

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about IDEAYA Biosciences Inc. stockHigh-return market picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

IDEAYA Biosciences: TD Cowen initiates coverage with Buy rating. - AInvest

Jul 22, 2025
pulisher
Jul 22, 2025

Promising Pipeline and Strategic Focus Drive Buy Rating for IDEAYA Biosciences - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

TD Cowen initiates Ideaya Biosciences stock with Buy rating By Investing.com - Investing.com Canada

Jul 22, 2025
pulisher
Jul 21, 2025

autocarpro> 2025> What analysts say about IDEAYA Biosciences Inc. stockPhenomenal trading returns - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

IDEAYA Biosciences CEO Fireside Chat: Precision Medicine Updates at BTIG Conference - Stock Titan

Jul 21, 2025
pulisher
Jul 16, 2025

(IDYA) Proactive Strategies - news.stocktradersdaily.com

Jul 16, 2025
pulisher
Jul 15, 2025

Why IDEAYA Biosciences Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How IDEAYA Biosciences Inc. stock performs during market volatilityDaily Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

Ideaya Biosciences stock gets Neutral rating from Goldman Sachs By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 10, 2025

Ideaya Biosciences price target lowered to $30 from $57 at RBC Capital - MSN

Jul 10, 2025
pulisher
Jul 10, 2025

Ideaya Biosciences shares fall 2.68% intraday as Biocytogen Pharmaceuticals enters into a global licensing agreement with BeOne Medicines. - AInvest

Jul 10, 2025
pulisher
Jul 10, 2025

RBC Capital Initiates IDEAYA Biosciences(IDYA.US) With Buy Rating, Announces Target Price $30 - 富途牛牛

Jul 10, 2025
pulisher
Jul 09, 2025

Ideaya Biosciences stock price target lowered to $30 by RBC Capital - Investing.com Canada

Jul 09, 2025
pulisher
Jul 09, 2025

RBC Cuts Price Target on IDEAYA Biosciences to $30 From $57, Keeps Outperform, Speculative Risk - MarketScreener

Jul 09, 2025
pulisher
Jul 07, 2025

Here's Why We're Watching IDEAYA Biosciences' (NASDAQ:IDYA) Cash Burn Situation - 富途牛牛

Jul 07, 2025
pulisher
Jul 06, 2025

(IDYA) Long Term Investment Analysis - news.stocktradersdaily.com

Jul 06, 2025
pulisher
Jun 30, 2025

IDEAYA Biosciences, Inc.(NasdaqGS:IDYA) dropped from Russell Small Cap Comp Growth Index - MarketScreener

Jun 30, 2025
pulisher
Jun 30, 2025

IDEAYA Biosciences: A Precision Oncology Play Gains Momentum with Russell 2000 Inclusion - AInvest

Jun 30, 2025
pulisher
Jun 29, 2025

Why IDEAYA's Russell Exit Could Be a Biotech Contrarian's Dream - AInvest

Jun 29, 2025
pulisher
Jun 28, 2025

IDEAYA Biosciences: A CFO's Deal-Making Expertise Could Be the Catalyst for a Breakout Year - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - PR Newswire

Jun 27, 2025
pulisher
Jun 26, 2025

This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Jun 26, 2025
pulisher
Jun 24, 2025

Ideaya Biosciences shareholders elect directors and approve auditor at annual meeting - Investing.com

Jun 24, 2025
pulisher
Jun 17, 2025

Rhumbline Advisers Increases Stock Holdings in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Holdings Lifted by GAMMA Investing LLC - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

Handelsbanken Fonder AB Raises Stock Position in IDEAYA Biosciences, Inc. (NASDAQ:IDYA) - Defense World

Jun 16, 2025
pulisher
Jun 16, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Comments on IDYA FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 09, 2025

Transcript : IDEAYA Biosciences, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-09-2025 10 - MarketScreener

Jun 09, 2025
pulisher
Jun 08, 2025

IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Shares Purchased by California State Teachers Retirement System - Defense World

Jun 08, 2025
pulisher
Jun 02, 2025

IDEAYA Biosciences to Participate in Upcoming June 2025 Investor Relations Events - PR Newswire

Jun 02, 2025

Ideaya Biosciences Inc Stock (IDYA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Cap:     |  Volume (24h):